Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Alexey M. Petrov"'
Publikováno v:
Nevrologiâ, Nejropsihiatriâ, Psihosomatika, Vol 13, Iss 1S, Pp 69-72 (2021)
The spread of the COVID-19 pandemic posed a serious challenge for scientific and clinical medical institutions in terms of research for new multiple sclerosis (MS) treatments. In this review we discuss the associations between coronavirus infection a
Publikováno v:
Nevrologiâ, Nejropsihiatriâ, Psihosomatika, Vol 11, Iss 4, Pp 125-129 (2019)
Patients with multiple sclerosis (MS) are at high risk for transition to secondary progressive MS (SPMS). To date, there has not been a sufficiently effective therapy for SPMS. Siponimod is a selective sphingosine-1-phosphate types 1 and 5 receptor m
Autor:
Anastasia A. Shvetsova, Daria V. Samoilova, V. M. Potekhina, Vlad S. Kuzmin, Alexandra Ivanova, Konstantin Ushenin, Alexey M. Petrov
Publikováno v:
The Journal of physiologyReferences. 599(11)
Key points The developmental changes of the caval (SVC) and pulmonary vein (PV) myocardium electrophysiology are traced throughout postnatal ontogenesis. The myocardium in SVC as well as in PV demonstrate age-dependent differences in the ability to m
Publikováno v:
Neuroscience and Behavioral Physiology. 47:540-543
This article presents published data and results from our own studies of the use of positron emission tomography (PET) with different radiotracers in multiple sclerosis (MS). Information on the principles of PET is given and grounds are presented for
Publikováno v:
Acta Naturae. 9:26-37
In our previous review, we described brain cholesterol metabolism in control conditions and in the case of some rare neurological pathologies linked to defects in the genes which are directly involved in the synthesis and/or traffic of cholesterol. H
Autor:
Alexey M. Petrov, Irina A. Pikuleva
Publikováno v:
Neurotherapeutics
Cholesterol 24-hydroxylation is the major mechanism for cholesterol removal from the brain and the reaction catalyzed by cytochrome P450 46A1 (CYP46A1), a CNS-specific enzyme. This review describes CYP46A1 in the context of cholesterol homeostasis in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::915141783de90322b49619bc4c9776d6
https://europepmc.org/articles/PMC6694357/
https://europepmc.org/articles/PMC6694357/
Autor:
Erin Maxfield, Natalia Mast, Irina A. Pikuleva, Alexey M. Petrov, Jean Moon, Young Li, Morrie Lam
Publikováno v:
SSRN Electronic Journal.
Efavirenz, the FDA-approved anti-retroviral medication, will soon be evaluated in the clinical trial in patients with mild cognitive impairment or early dementia due to Alzheimer's disease. Efavirenz will be assessed for activation of cytochrome P450
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 116(2 Pt 2)
The article presents the literature data and results of our own researchon the use of positron emission tomography (PET) with different radiotracersin multiple sclerosis (MS). Informationon the operating principles of PET and PET studies with differe
Publikováno v:
The FASEB Journal. 26
Autor:
Guy Kornbeg, Capece Mark, Sean T. O’Leary, Jin Chen, Joseph D. Puglisi, Albert Tsai, Alexey M. Petrov, Magnus Jonansson
Publikováno v:
Seibutsu Butsuri. 53:S87